C12Y 304/24007
Interstitial collagenase , i.e. matrix metalloprotease 1 or mmp1
Official title: Interstitial collagenase (3.4.24.7), i.e. matrix metalloprotease 1 or MMP1
C12Y304/24007 (Interstitial collagenase , i.e. matrix metalloprotease 1 or mmp1) appears on 82 US grants and 154 published applications in this corpus.
Search patents in C12Y- Granted patents
- 82
- Published applications
- 154
- Assignees
- 81
- Inventors
- 206
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 2 |
| 2007 | 0 | 1 |
| 2008 | 0 | 2 |
| 2009 | 2 | 5 |
| 2010 | 2 | 6 |
| 2011 | 2 | 12 |
| 2012 | 2 | 2 |
| 2013 | 4 | 7 |
| 2014 | 3 | 6 |
| 2015 | 6 | 11 |
| 2016 | 5 | 12 |
| 2017 | 6 | 14 |
| 2018 | 5 | 5 |
| 2019 | 10 | 9 |
| 2020 | 5 | 10 |
| 2021 | 6 | 15 |
| 2022 | 4 | 7 |
| 2023 | 5 | 6 |
| 2024 | 7 | 7 |
| 2025 | 5 | 6 |
| 2026 | 3 | 8 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods of reducing collagenase-mediated bruising in a subject having cellulite30 Jun 2026US 12,667,607 B2Endo Operations Limited
- Nanomaterials containing constrained lipids and uses thereof10 Mar 2026US 12,569,438 B2Georgia Tech Research Corporation
- Composition comprising collagenase, calcium, histidine, and glycine, and method for stabilizing collagenase6 Jan 2026US 12,516,310 B2Connext Limited
- Methods for treating NETosis and neutrophil activation14 Oct 2025US 12,440,545 B2Trustees of Boston University
- Compositions for remodeling extracellular matrix and methods of use thereof1 Jul 2025US 12,343,386 B2NanoCell Ltd.
- Nanomaterials containing constrained lipids and uses thereof13 Aug 2026US 2026/0232587 A1Georgia Tech Research Corporation
- Composition comprising mir-499-5p activator for preventing or treating duchenne muscular dystrophy6 Aug 2026US 2026/0224631 A1Encell Co., Ltd.
- Thermosensitive hydrogel collagenase formulations30 Apr 2026US 2026/0115264 A1ENDO Biologics, Inc.
- Methods for nucleic acid extraction from tissues9 Apr 2026US 2026/0098251 A1Waters Technologies Corporation
- Methods for treating netosis and neutrophil activation19 Mar 2026US 2026/0077028 A1Trustees of Boston University
Most cited
By later US patents
- Reduced-pressure treatment systems and methods employing debridement mechanisms75US 8,486,032 B2KCI Licensing, Inc. · 2013
- Hyaline cartilage shaping28US 10,603,059 B2Aerin Medical Inc. · 2020
- Compositions and methods for treating collagen-mediated diseases19US 7,811,560 B2Auxilium US Holdings, LLC · 2010
- Contact lens use in the treatment of an ophthalmologic condition14US 9,086,580 B2Osio Corporation · 2015
- Fusion proteins of collagen-binding domain and parathyroid hormone12US 8,450,273 B2Board of Trustees of the University of Arkansas · 2013